Cyient's profit fell 31.7 per cent quarter-on-quarter (Q-o-Q) to Rs 122.3 crore in Q3FY25, from 179.1 crore in the September ...

Nuvama is Cautious in ITC. This is because of continued concerns in the FMCG segment and the market anticipating a potential ...

Nuvama slashed its FY25 and 26 EPS estimates by 10.8 per cent and 4.5 per cent, respectively, on lower growth and margins. It ...

The fund focuses on Grade A+ office spaces across key micro-markets in India's six largest cities: Bengaluru, the National ...

Spandana Sphoorty Financial fell 5 per cent to Rs 324.65. The stock has lost 54 per cent of its market value in the past six months and 70 per cent in the past one year.

At around 10:21 am, shares of Cyient were down 17.96% to Rs 1,438 on the Bombay Stock Exchange (BSE). In early trade, shares ...

NCW, a JV between Nuvama Asset Management and Cushman & Wakefield, has raised Rs 1,700 crore for its Prime Offices Fund to ...

Nuvama Asset Management and Cushman & Wakefield have raised Rs 1,700 crore for their first real estate fund. They aim to ...

Nuvama retains 'Buy' rating on HDFC Bank, citing strong results in a tough macro environment. Discover the details behind ...

Nuvama-Cushman & Wakefield JV raises ₹1,700 crore for Prime Offices Fund targeting India's commercial real estate sector.

Revlimid, which has arguably been the single biggest growth driver for Dr Reddy's in recent years, is set to go off patent in ...